Healthpeak Properties (NYSE:DOC – Free Report) had its price objective reduced by Wells Fargo & Company from $19.00 to $18.00 in a research note published on Monday, Marketbeat Ratings reports. They currently have an equal weight rating on the real estate investment trust’s stock.
A number of other research firms have also commented on DOC. Jefferies Financial Group lowered shares of Healthpeak Properties from a “buy” rating to a “hold” rating and cut their price objective for the company from $21.00 to $17.00 in a research report on Monday, December 15th. Evercore ISI lowered their target price on shares of Healthpeak Properties from $22.00 to $21.00 and set an “outperform” rating on the stock in a research note on Monday, December 15th. The Goldman Sachs Group assumed coverage on shares of Healthpeak Properties in a research report on Friday, January 9th. They set a “neutral” rating and a $17.00 price target for the company. Weiss Ratings upgraded Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, January 26th. Finally, Cantor Fitzgerald set a $17.00 price objective on Healthpeak Properties in a research note on Monday, January 5th. Seven analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $19.42.
Check Out Our Latest Stock Report on DOC
Healthpeak Properties Price Performance
Healthpeak Properties (NYSE:DOC – Get Free Report) last released its quarterly earnings data on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.45 by $0.02. The company had revenue of $719.40 million for the quarter, compared to analyst estimates of $685.14 million. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.The firm’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, equities research analysts forecast that Healthpeak Properties will post 1.86 EPS for the current year.
Healthpeak Properties Dividend Announcement
The business also recently disclosed a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be issued a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a dividend yield of 7.3%. The ex-dividend date of this dividend is Tuesday, March 17th. Healthpeak Properties’s payout ratio is currently 1,220.00%.
Institutional Investors Weigh In On Healthpeak Properties
A number of large investors have recently added to or reduced their stakes in the company. Mather Group LLC. purchased a new position in shares of Healthpeak Properties in the 3rd quarter worth about $25,000. City Holding Co. purchased a new position in shares of Healthpeak Properties during the 3rd quarter valued at about $26,000. WPG Advisers LLC lifted its position in Healthpeak Properties by 270.2% in the 4th quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock worth $26,000 after buying an additional 1,197 shares during the last quarter. Rexford Capital Inc. purchased a new stake in Healthpeak Properties in the second quarter worth approximately $28,000. Finally, Sound Income Strategies LLC purchased a new stake in Healthpeak Properties in the third quarter worth approximately $28,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.
About Healthpeak Properties
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
See Also
- Five stocks we like better than Healthpeak Properties
- The day the gold market broke
- Buy this Gold Stock Before May 2026
- Forget AI, This Will Be the Next Big Tech Breakthrough
- Trump Planning to Use Public Law 63-43: Prepare Now
- New gold price target
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
